Parabilis Medicines, Inc (PBLS)
NGS · Common
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PBLS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
Business: Parabilis Medicines, Inc is a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease.

Company Contact

CEO
Mathai Mammen
CFO
Thomas Kotarakos
Headquarters
30 Acorn Park Drive ,ambridge, MA 02140
Phone
607-945-9510
Investor Relations
Tom Kotarakos · investors@parabilismed.com
SEC EDGAR Filings
View filings »